Skip to content
  • Contact Us
  • Careers
  • LinkedIn
  • X (Twitter)
  • Email us
Allogene Therapeutics
  • PIPELINE
    • AlloCAR T PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY
  • PIPELINE
  • SCIENCE
  • ABOUT US
  • NEWS CENTER
  • INVESTORS

COOKIE POLICY

Please read this cookie policy for more details before giving your consent.

You can prevent your data from being collected by Google Analytics on our Site by downloading and installing the Google Analytics Opt-out Browser Add-on for your current web browser at the following link: Google Analytics Opt-out Browser Add-on

Changes to this policy

This policy is effective from June 30, 2020. We may change this policy from time to time by updating this webpage.

Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

Phone: 650-457-2700

View Map / Contact Us

LinkedInX (Twitter)
  • PIPELINE
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry

Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

Phone: 650-457-2700

View Map / Contact Us

LinkedInX (Twitter)
  • PIPELINE
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry

©2026 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE

©2026 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE

Facebook X (Twitter) LinkedIn E-Mail Tumblr Reddit WhatsApp Telegram